Sobi enters licence agreement for ADC’s Zynlonta
Out of total payment of up to $435m, ADC Therapeutics will get an upfront payment of $55m from Sobi.

Out of total payment of up to $435m, ADC Therapeutics will get an upfront payment of $55m from Sobi.
Redbiotec is entitled to receive royalty payments on Eurocine’s net sales of an approved HSV-2 vaccine.
People who received the first dose of AstraZeneca’s shot and the second dose of Pfizer-BioNTech’s vaccine had a 67% low…
Recent data points to an increased risk of myocarditis and pericarditis among younger age groups who receive Spikevax.
Sobi has more than ten late-stage R&D programmes that are intended for areas with unmet medical needs.
Mesdopetam is presently being assessed in Phase IIb trials for treating Parkinson’s patients experiencing involuntary movements.
Immune System Regulation (ISR) has entered an agreement to develop an inhaled Covid-19 vaccine in Iconovo's ICOone inhaler.
Clinical stage firm BioInvent International and Cantargia have signed a manufacturing agreement for monoclonal antibody CAN10 to treat systemic sclerosis…
Thank you for subscribing to Pharmaceutical Technology